Catalyst Wire Dossier Catalyst Wire Dossier

Revestive

teduglutide · Takeda
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Revestive, covering 2025-05-23 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients [Phase 4]

See pricing